Precision Therapeutics Inc. Separation Agreements
4 Contracts & Agreements
- Separation Agreement and Mutual Release dated effective September 30, 2023, by and between the Company and Bob Myers (Filed With SEC on March 28, 2024)
- Transition and Separation Agreement dated September 15, 2022 by and between J. Melville Engle and Predictive Oncology Inc (Filed With SEC on September 16, 2022)
- Transition and Separation Agreement by and between the Company and Carl Schwartz dated March 19, 2021 (Filed With SEC on March 23, 2021)
- SEPARATION AGREEMENT AND RELEASE (Filed With SEC on June 17, 2016)